PHGDH and neoplasm: To determine the impact of serine/glycine limitation on circulating and tumour levels of hypoxanthine, we analysed serum and tumours from mice carrying DLD-1 xenograft tumours and treated with a serine/glycine-free diet in combination with the PHGDH inhibitor, PH755.